These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8969453)

  • 21. Anthracycline assay by high-pressure liquid chromatography.
    Averbuch SD; Finkelstein TT; Fandrich SE; Reich SD
    J Pharm Sci; 1981 Mar; 70(3):265-9. PubMed ID: 6943332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of rubidazone and its metabolites in human plasma and urine by reversed-phase ion-pair high-performance liquid chromatography.
    Nguyen-Huu JJ; Turk P; Diquet B
    J Chromatogr; 1986 Aug; 380(2):455-61. PubMed ID: 3760077
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid quantitative determination of doxorubicin and its metabolites in biological samples.
    Sqalli A; Labat C; Oustrin J; Houin G; Coulais Y; Bugat R; Carton P
    Ann Biol Clin (Paris); 1989; 47(2):63-6. PubMed ID: 2735565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of temperature, daunorubicin concentration and suspension hematocrit on daunorubicin binding by human erythrocytes].
    Ataullakhanov FI; Batasheva TV; Vitvitskiĭ VM
    Antibiot Khimioter; 1994; 39(9-10):26-9. PubMed ID: 7695445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intracellular measurement of anthracyclines with flow cytometry].
    Dorn A; Graf N; Pees HW
    Padiatr Padol; 1993; 28(6):157-63. PubMed ID: 8302622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy and toxicity of doxorubicin encapsulated in glutaraldehyde-treated erythrocytes administered to dogs with lymphosarcoma.
    Matherne CM; Satterfield WC; Gasparini A; Tonetti M; Astroff AB; Schmidt RD; Rowe LD; DeLoach JR
    Am J Vet Res; 1994 Jun; 55(6):847-53. PubMed ID: 7944027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and tissue distribution of dual-targeting daunorubicin liposomes in mice.
    Ying X; Wen H; Yao HJ; Zhang Y; Tian W; Zhang L; Ju RJ; Wang XX; Yu Y; Lu WL
    Pharmacology; 2011; 87(1-2):105-14. PubMed ID: 21282968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo liver and lung targeting of adriamycin encapsulated in glutaraldehyde-treated murine erythrocytes.
    Zocchi E; Tonetti M; Polvani C; Guida L; Benatti U; De Flora A
    Biotechnol Appl Biochem; 1988 Dec; 10(6):555-62. PubMed ID: 3148305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of glutaraldehyde treatment on enzyme-loaded erythrocytes.
    Deloach J; Peters S; Pinkard O; Glew R; Ihler G
    Biochim Biophys Acta; 1977 Feb; 496(2):507-15. PubMed ID: 402162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of pirarubicin in plasma and cerebrospinal fluid.
    Morikawa N; Takeyama M; Mori T; Hori S
    Ann Pharmacother; 1998 Feb; 32(2):269. PubMed ID: 9496418
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anthracycline transport in sensitive and resistant leukemia cells].
    Erttmann R; Erb N; Forcadell de Dios P; Neurath C; Looft G; Landbeck G
    Klin Padiatr; 1989; 201(1):40-5. PubMed ID: 2704176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte entrapment of daunomycin by amphotericin B without hemolysis.
    Kitao T; Hattori K
    Cancer Res; 1980 Apr; 40(4):1351-3. PubMed ID: 7357561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of glutaraldehyde-treated erythrocytes for assaying the agglutinating activity of lectins.
    Turner RH; Liener IE
    Anal Biochem; 1975 Oct; 68(2):651-3. PubMed ID: 812379
    [No Abstract]   [Full Text] [Related]  

  • 34. Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect.
    Schlage P; Mezo G; Orbán E; Bosze S; Manea M
    J Control Release; 2011 Dec; 156(2):170-8. PubMed ID: 21864594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia.
    Bellott R; Auvrignon A; Leblanc T; Pérel Y; Gandemer V; Bertrand Y; Méchinaud F; Bellenger P; Vernois J; Leverger G; Baruchel A; Robert J
    Cancer Chemother Pharmacol; 2001; 47(1):15-21. PubMed ID: 11221955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model.
    Berg SL; Reid J; Godwin K; Murry DJ; Poplack DG; Balis FM; Ames MM
    J Pediatr Hematol Oncol; 1999; 21(1):26-30. PubMed ID: 10029808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some signal effects in human erythrocytes on specific binding of free doxorubicin and doxorubicin conjugates with magnetite nanoparticles.
    Mykhaylyk OM; Kotsuruba AV; Dudchenko NO; Törok G
    Ukr Biokhim Zh (1999); 2005; 77(4):84-92. PubMed ID: 16568608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).
    Zara GP; Cavalli R; Fundarò A; Bargoni A; Caputo O; Gasco MR
    Pharmacol Res; 1999 Sep; 40(3):281-6. PubMed ID: 10479474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol.
    Hempel G; Relling MV; de Rossi G; Stary J; De Lorenzo P; Valsecchi MG; Barisone E; Boos J; Pieters R
    Pediatr Blood Cancer; 2010 Mar; 54(3):355-60. PubMed ID: 19731319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of anthracyclines by cellular peroxidase.
    Reszka KJ; Wagner BA; Teesch LM; Britigan BE; Spitz DR; Burns CP
    Cancer Res; 2005 Jul; 65(14):6346-53. PubMed ID: 16024637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.